Literature DB >> 14710116

Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage.

Catherine C Davis1, Mary J Kremer, Patrick M Schlievert, Christopher A Squier.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate transvaginal penetration of toxic shock syndrome toxin-1 and its effects on permeability and tissue integrity in vitro with the use of excised porcine vaginal mucosa. STUDY
DESIGN: Permeability to tritiated water (1 and 10 microg/mL applied toxin) and transmucosal flux of (35)S-methionine-labeled toxic shock syndrome toxin-1 (10 and 20 microg/mL) for up to 12 hours were assessed with the use of a continuous flow perfusion system. The location of labeled toxin that penetrated the mucosal tissue strata was determined. The integrity of toxin-treated, intact, scalpel-incised tissue was evaluated histopathologically.
RESULTS: Toxic shock syndrome toxin-1 caused a non-dose-dependent increase in mucosal permeability and traversed the intact mucosa at a low rate without disrupting tissue integrity. In incised vaginal mucosa, toxic shock syndrome toxin-1 induced subepithelial separation and atrophy that were analogous to clinically relevant vaginal lesions that were reported in fatal cases of menstrual toxic shock syndrome.
CONCLUSION: An in vitro model could be used to demonstrate that toxic shock syndrome toxin-1 permeates the vaginal mucosa and distributes throughout the tissue. Histologic evaluation of tissues that were exposed to toxic shock syndrome toxin-1 demonstrated lesions that were similar to those lesions that were reported in cases of menstrual toxic shock syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710116     DOI: 10.1016/s0002-9378(03)00873-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  20 in total

1.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).

Authors:  Laura M Breshears; Patrick M Schlievert; Marnie L Peterson
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

3.  Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Mary L Delaney; Paul A Modern; Andrea M Dubois; Wendy Wieland-Alter; Kimberly W Wissemann; John E Wild; Michaelle B Jones; Jon L Seymour; Andrew B Onderdonk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Vaginal Tampon Colonization by Staphylococcus aureus in Healthy Women.

Authors:  Myriam Chiaruzzi; Alexia Barbry; Anaëlle Muggeo; Anne Tristan; Isaline Jacquemond; Cedric Badiou; Laurence Cluzeau; Sabine Bourdeau; Thibaut Durand; Astrid Engelmann; Dorian Bosquet; Michèle Bes; Claire Prigent-Combaret; Jean Thioulouse; Daniel Muller; Gérard Lina
Journal:  Appl Environ Microbiol       Date:  2020-09-01       Impact factor: 4.792

5.  Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production In Vitro.

Authors:  Louis Nonfoux; Myriam Chiaruzzi; Cédric Badiou; Jessica Baude; Anne Tristan; Jean Thioulouse; Daniel Muller; Claire Prigent-Combaret; Gérard Lina
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

6.  The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.

Authors:  Marnie L Peterson; Kevin Ault; Mary J Kremer; Aloysius J Klingelhutz; Catherine C Davis; Christopher A Squier; Patrick M Schlievert
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Jon L Seymour; Mary L Delaney; Andrea M Dubois; Paul A Modern; Michaelle B Jones; John E Wild; Andrew B Onderdonk
Journal:  BMC Infect Dis       Date:  2010-08-23       Impact factor: 3.090

9.  Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.

Authors:  Roderick A MacPhee; Wayne L Miller; Gregory B Gloor; John K McCormick; Jo-Anne Hammond; Jeremy P Burton; Gregor Reid
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

10.  Cytolysins augment superantigen penetration of stratified mucosa.

Authors:  Amanda J Brosnahan; Mary J Mantz; Christopher A Squier; Marnie L Peterson; Patrick M Schlievert
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.